| Autor: |
Abraham E; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK., Lawther HA; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK., Wang Y; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK., Zarins-Tutt JS; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK., Rivera GS; Intact Genomics, St. Louis, MO 63132, USA., Wu C; Intact Genomics, St. Louis, MO 63132, USA., Connolly JA; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK., Florence G; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK., Agbo M; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK., Gao H; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK., Goss RJM; Department of Chemistry & BSRC, University of St. Andrews, St. Andrews KY16 9ST, UK. |
| Abstrakt: |
With the rise in antimicrobial resistance, there is an urgent need for new classes of antibiotic with which to treat infectious disease. Marinomycin, a polyene antibiotic from a marine microbe, has been shown capable of killing methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF), as well as having promising activity against melanoma. An attractive solution to the photoprotection of this antibiotic has been demonstrated. Here, we report the identification and analysis of the marinomycin biosynthetic gene cluster (BGC), and the biosynthetic assembly of the macrolide. The marinomycin BGC presents a challenge in heterologous expression due to its large size and high GC content, rendering the cluster prone to rearrangement. We demonstrate the transformation of Streptomyces lividans using a construct containing the cluster, and the heterologous expression of the encoded biosynthetic machinery and production of marinomycin B. |
